Capabilities
Hongbaek's processing technologies and equipment
From high-content ginsenoside concentration through bioconversion, nanoliposome, and freeze drying, we talk only about technology that can be shown in documents.
Core Abilities
From design to manufacturing, and on to new materials
Our capabilities come together when these three abilities connect within one plant. We manufacture what we design, and the data from production feeds back into new material development.
01Formulation designWe plan the early stages of health functional food development, from material formulation to verification of effects on the human body and efficacy confirmation.
02Ingredient manufacturingWe have the capacity to mass-produce special materials and a range of formulation equipment, and we produce health functional food materials steadily under GMP standards.
03New ingredient developmentLed by the dedicated research department, we develop next-generation ginseng materials such as Rg3 and compound K raw materials and freeze-dried products.
Results
Two results of the three abilities
| Result | Why it matters |
|---|---|
| Ingredients with high concentrations of target components | A core part of combined health functional foods: when several materials have to share one tablet, a material that reaches the standard content in a small amount widens the range of the design. |
| High-purity ingredients | A core part of meeting the market on time: high-purity purification raises the target component, so we can respond quickly to the specification a product plan calls for. |
Technology
Six core technologies
01High-content ginsenoside concentration technologyThis is the concentration technology behind the freeze-dried powder with a combined Rg1 + Rb1 + Rg3 content of 100 mg/g (product manufacturing report No. 202500286918).
02Rg3 and compound K bioconversion technologyThis technology converts ginsenosides commonly found in red ginseng into the rare components Rg3 and compound K, so that we can supply these rare ginsenoside raw materials at mass-production scale.
03Nanoliposome manufacturing technologyThis formulation technology encloses a material in a fine phospholipid membrane, allowing materials with challenging physical properties to be used in various product formats.
04Natural material extraction and concentration technologyWe have extraction and concentration lines for a range of natural materials, including ginseng, and design processes around each raw material, including for toll processing.
05High-purity purification technologyOur column purification lines increase the purity of the target component. We produce both high-content and high-purity raw materials within the same plant.
06Concentration and freeze-drying equipmentWe operate high-content ginsenoside concentration equipment and freeze-drying equipment directly at the Geumsan plant.
Production Lines
From raw ginseng to processed materials: three production lines
Extraction and ConcentrationExtraction and concentration lineThe initial process extracts and concentrates active components from raw materials. It is the starting point for high-content materials.
Column PurificationColumn purification lineThe purification process that raises the purity of the target component in the concentrate. High-purity raw material is made here.
Freeze DryingFreeze-drying lineThe last process, removing only the moisture while limiting changes to the components. We operate freeze-drying equipment directly at the Geumsan plant.B2B Materials
Two materials made possible by our technology
Red Ginseng Concentrate 60Combined Rg1 + Rb1 + Rg3 content of 60 mg/gProduct manufacturing report No. 202500286917, December 2025. A red ginseng concentrate for which a product manufacturing report was filed with a combined ginsenoside content of 60 mg/g.
Red Ginseng Concentrate Powder 100Combined Rg1 + Rb1 + Rg3 content of 100 mg/gProduct manufacturing report No. 202500286918, January 2026. A freeze-dried red ginseng concentrate powder for which a product manufacturing report was filed with a combined ginsenoside content of 100 mg/g.Documents
Technology checked through documents
Patent certificates, product manufacturing report certificates, test and inspection certificates, and sales business report certificates. Everything we say about our technology can be checked in a document.
Patent certificate No. 10-1380205Moist-heat-sterilized ginseng powder and method for manufacturing the same
Patent certificate No. 10-1859166Composition for relieving hangover containing a ginseng-containing herbal extract
Patent certificate No. 10-1870280Composition for relieving hangover containing cinnamon and the petiole of the cinnamon tree as an active ingredient
Product manufacturing report certificateRed Ginseng Concentrate 60, No. 202500286917
Product manufacturing report certificateRed Ginseng Concentrate Powder 100 mg/g, No. 202500286918
Test and inspection certificateRed Ginseng Concentrate 60, November 2025
Test and inspection certificateRed Ginseng Concentrate Powder 100, January 2026
Sales business report certificateHealth functional food sales business, No. 2022-0653002